GlassScriptPhysician profile
Matthew J Iwinski
NPI 1275535387
$2,365.21
in general payments reported to CMS, 2019-2025
8 companies · $466 in 2025
The $466 reported for 2025 was more than what 90% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $523 · 2021: $99.00 · 2022: $184 · 2023: $200 · 2024: $422 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $447 · Food and Beverage: $302 · Consulting Fee: $200 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $446.96 |
| Food and Beverage | $301.70 |
| Consulting Fee | $200.00 |
| Education | $140.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $630.94 | 2022-2025 | Opalescence |
| Dentsply LLC | $602.24 | 2019-2023 | |
| Straumann USA LLC | $321.50 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $267.00 | 2019-2020 | |
| 3m Company | $263.33 | 2020 | |
| Geistlich Pharma, North America, INC. | $164.42 | 2024-2025 | Geistlich Bio-Gide, Biomaterials |
| Hu-Friedy Mfg. Co., LLC | $100.00 | 2020-2025 | |
| Elevate Oral Care | $15.78 | 2024 | Fluorimax Mint, Fluorimax 5000, Just Right 5000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Iwinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.